Oligomeric forms of amyloid-β protein in plasma as a potential blood-based biomarker for Alzheimer’s disease

Oligomeric forms of amyloid-β protein in plasma as a potential blood-based biomarker for Alzheimer’s disease

Abstract Background Soluble amyloid-β (Aβ) oligomers are the major toxic substances associated with the pathology of Alzheimer’s disease (AD). The ability to measure Aβ oligomer levels in the blood would provide simple and minimally invasive tools for AD diagnostics. In the present study, the recent...

Full description

Bibliographic Details
Main Authors: Min Jeong Wang, SangHak Yi, Jee-young Han, So Young Park, Jae-Won Jang, In Kook Chun, Sang Eun Kim, Byoung Sub Lee, Gwang Je Kim, Ji Sun Yu, Kuntaek Lim, Sung Min Kang, Young Ho Park, Young Chul Youn, Seong Soo A. An, SangYun Kim
Format: Article
Language:English
Published: BMC 2017-12-01
Series:Alzheimer’s Research & Therapy
Subjects:
Amyloid-β protein
Oligomer
Alzheimer’s disease
Biomarker
Online Access:http://link.springer.com/article/10.1186/s13195-017-0324-0

Internet

http://link.springer.com/article/10.1186/s13195-017-0324-0

Similar Items